4/24
10:00 am
tars
Tarsus Pharmaceuticals (TARS) is now covered by Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $98.00 price target on the stock.
Low
Report
Tarsus Pharmaceuticals (TARS) is now covered by Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $98.00 price target on the stock.
2/25
12:43 pm
tars
Rating for TARS
Medium
Report
Rating for TARS
2/25
12:43 pm
tars
Rating for TARS
Medium
Report
Rating for TARS
2/25
09:23 am
tars
Rating for TARS
Medium
Report
Rating for TARS
2/25
09:23 am
tars
Rating for TARS
Medium
Report
Rating for TARS